SS

Sarkis Serge Messerlian

Active Director Additional Director DIN 11357494
DIN 11357494 First appointment Dec 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2025
Shareholding value •••• Premium profile

About Sarkis Serge Messerlian

Data last updated:

Sarkis Serge Messerlian is an Additional Director at Creyon Bio India Private Limited (since 2025). The company operates in Pharma. Creyon Bio India Private Limited reported revenue of ₹14.09 Cr (FY 2026).

DIN 11357494
Primary Designation Additional Director
Industry Pharma
First Appointment 09 Dec 2025
Largest company Creyon Bio India Private Limited · ₹14.09 Cr (FY 2026)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Creyon Bio India Private Limited U72100KA2023FTC173910
Additional Director09 Dec 2025₹14.09 Cr (FY 2026)Active

Board colleagues of Sarkis Serge Messerlian

Directorship timeline

Open interactive timeline →
Creyon Bio India Private Limited
Premium access

Shareholding and investment profile for Sarkis Serge Messerlian

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sarkis Serge Messerlian

Sarkis Serge Messerlian currently holds 1 directorship: Creyon Bio India Private Limited (Additional Director, since 09 Dec 2025, revenue ₹14.09 Cr (FY 2026)).

Sarkis Serge Messerlian was first appointed on 09 Dec 2025 as Additional Director at Creyon Bio India Private Limited.

The current boards of Sarkis Serge Messerlian's companies include Jeyaprakash Narayanan Seenisamy (Creyon Bio India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available